Literature DB >> 22928564

Interactions between genetic background, insulin resistance and β-cell function.

S E Kahn1, S Suvag, L A Wright, K M Utzschneider.   

Abstract

An interaction between genes and the environment is a critical component underlying the pathogenesis of the hyperglycaemia of type 2 diabetes. The development of more sophisticated techniques for studying gene variants and for analysing genetic data has led to the discovery of some 40 genes associated with type 2 diabetes. Most of these genes are related to changes in β-cell function, with a few associated with decreased insulin sensitivity and obesity. Interestingly, using quantitative traits based on continuous measures rather than dichotomous ones, it has become evident that not all genes associated with changes in fasting or post-prandial glucose are also associated with a diagnosis of type 2 diabetes. Identification of these gene variants has provided novel insights into the physiology and pathophysiology of the β-cell, including the identification of molecules involved in β-cell function that were not previously recognized as playing a role in this critical cell. Published 2012. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2012        PMID: 22928564      PMCID: PMC3634618          DOI: 10.1111/j.1463-1326.2012.01650.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  74 in total

Review 1.  Genomics, type 2 diabetes, and obesity.

Authors:  Mark I McCarthy
Journal:  N Engl J Med       Date:  2010-12-09       Impact factor: 91.245

2.  β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition.

Authors:  Catherine A Jurgens; Mirna N Toukatly; Corinne L Fligner; Jayalakshmi Udayasankar; Shoba L Subramanian; Sakeneh Zraika; Kathryn Aston-Mourney; Darcy B Carr; Per Westermark; Gunilla T Westermark; Steven E Kahn; Rebecca L Hull
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.

Authors:  Benjamin F Voight; Laura J Scott; Valgerdur Steinthorsdottir; Andrew P Morris; Christian Dina; Ryan P Welch; Eleftheria Zeggini; Cornelia Huth; Yurii S Aulchenko; Gudmar Thorleifsson; Laura J McCulloch; Teresa Ferreira; Harald Grallert; Najaf Amin; Guanming Wu; Cristen J Willer; Soumya Raychaudhuri; Steve A McCarroll; Claudia Langenberg; Oliver M Hofmann; Josée Dupuis; Lu Qi; Ayellet V Segrè; Mandy van Hoek; Pau Navarro; Kristin Ardlie; Beverley Balkau; Rafn Benediktsson; Amanda J Bennett; Roza Blagieva; Eric Boerwinkle; Lori L Bonnycastle; Kristina Bengtsson Boström; Bert Bravenboer; Suzannah Bumpstead; Noisël P Burtt; Guillaume Charpentier; Peter S Chines; Marilyn Cornelis; David J Couper; Gabe Crawford; Alex S F Doney; Katherine S Elliott; Amanda L Elliott; Michael R Erdos; Caroline S Fox; Christopher S Franklin; Martha Ganser; Christian Gieger; Niels Grarup; Todd Green; Simon Griffin; Christopher J Groves; Candace Guiducci; Samy Hadjadj; Neelam Hassanali; Christian Herder; Bo Isomaa; Anne U Jackson; Paul R V Johnson; Torben Jørgensen; Wen H L Kao; Norman Klopp; Augustine Kong; Peter Kraft; Johanna Kuusisto; Torsten Lauritzen; Man Li; Aloysius Lieverse; Cecilia M Lindgren; Valeriya Lyssenko; Michel Marre; Thomas Meitinger; Kristian Midthjell; Mario A Morken; Narisu Narisu; Peter Nilsson; Katharine R Owen; Felicity Payne; John R B Perry; Ann-Kristin Petersen; Carl Platou; Christine Proença; Inga Prokopenko; Wolfgang Rathmann; N William Rayner; Neil R Robertson; Ghislain Rocheleau; Michael Roden; Michael J Sampson; Richa Saxena; Beverley M Shields; Peter Shrader; Gunnar Sigurdsson; Thomas Sparsø; Klaus Strassburger; Heather M Stringham; Qi Sun; Amy J Swift; Barbara Thorand; Jean Tichet; Tiinamaija Tuomi; Rob M van Dam; Timon W van Haeften; Thijs van Herpt; Jana V van Vliet-Ostaptchouk; G Bragi Walters; Michael N Weedon; Cisca Wijmenga; Jacqueline Witteman; Richard N Bergman; Stephane Cauchi; Francis S Collins; Anna L Gloyn; Ulf Gyllensten; Torben Hansen; Winston A Hide; Graham A Hitman; Albert Hofman; David J Hunter; Kristian Hveem; Markku Laakso; Karen L Mohlke; Andrew D Morris; Colin N A Palmer; Peter P Pramstaller; Igor Rudan; Eric Sijbrands; Lincoln D Stein; Jaakko Tuomilehto; Andre Uitterlinden; Mark Walker; Nicholas J Wareham; Richard M Watanabe; Gonçalo R Abecasis; Bernhard O Boehm; Harry Campbell; Mark J Daly; Andrew T Hattersley; Frank B Hu; James B Meigs; James S Pankow; Oluf Pedersen; H-Erich Wichmann; Inês Barroso; Jose C Florez; Timothy M Frayling; Leif Groop; Rob Sladek; Unnur Thorsteinsdottir; James F Wilson; Thomas Illig; Philippe Froguel; Cornelia M van Duijn; Kari Stefansson; David Altshuler; Michael Boehnke; Mark I McCarthy
Journal:  Nat Genet       Date:  2010-07       Impact factor: 38.330

4.  Consistent association of type 2 diabetes risk variants found in europeans in diverse racial and ethnic groups.

Authors:  Kevin M Waters; Daniel O Stram; Mohamed T Hassanein; Loïc Le Marchand; Lynne R Wilkens; Gertraud Maskarinec; Kristine R Monroe; Laurence N Kolonel; David Altshuler; Brian E Henderson; Christopher A Haiman
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

5.  A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.

Authors:  Laura J Scott; Karen L Mohlke; Lori L Bonnycastle; Cristen J Willer; Yun Li; William L Duren; Michael R Erdos; Heather M Stringham; Peter S Chines; Anne U Jackson; Ludmila Prokunina-Olsson; Chia-Jen Ding; Amy J Swift; Narisu Narisu; Tianle Hu; Randall Pruim; Rui Xiao; Xiao-Yi Li; Karen N Conneely; Nancy L Riebow; Andrew G Sprau; Maurine Tong; Peggy P White; Kurt N Hetrick; Michael W Barnhart; Craig W Bark; Janet L Goldstein; Lee Watkins; Fang Xiang; Jouko Saramies; Thomas A Buchanan; Richard M Watanabe; Timo T Valle; Leena Kinnunen; Gonçalo R Abecasis; Elizabeth W Pugh; Kimberly F Doheny; Richard N Bergman; Jaakko Tuomilehto; Francis S Collins; Michael Boehnke
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

6.  Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.

Authors:  Jose M de Miguel-Yanes; Peter Shrader; Michael J Pencina; Caroline S Fox; Alisa K Manning; Richard W Grant; Josèe Dupuis; Jose C Florez; Ralph B D'Agostino; L Adrienne Cupples; James B Meigs
Journal:  Diabetes Care       Date:  2010-10-01       Impact factor: 19.112

7.  Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.

Authors:  Rona J Strawbridge; Josée Dupuis; Inga Prokopenko; Adam Barker; Emma Ahlqvist; Denis Rybin; John R Petrie; Mary E Travers; Nabila Bouatia-Naji; Antigone S Dimas; Alexandra Nica; Eleanor Wheeler; Han Chen; Benjamin F Voight; Jalal Taneera; Stavroula Kanoni; John F Peden; Fabiola Turrini; Stefan Gustafsson; Carina Zabena; Peter Almgren; David J P Barker; Daniel Barnes; Elaine M Dennison; Johan G Eriksson; Per Eriksson; Elodie Eury; Lasse Folkersen; Caroline S Fox; Timothy M Frayling; Anuj Goel; Harvest F Gu; Momoko Horikoshi; Bo Isomaa; Anne U Jackson; Karen A Jameson; Eero Kajantie; Julie Kerr-Conte; Teemu Kuulasmaa; Johanna Kuusisto; Ruth J F Loos; Jian'an Luan; Konstantinos Makrilakis; Alisa K Manning; María Teresa Martínez-Larrad; Narisu Narisu; Maria Nastase Mannila; John Ohrvik; Clive Osmond; Laura Pascoe; Felicity Payne; Avan A Sayer; Bengt Sennblad; Angela Silveira; Alena Stancáková; Kathy Stirrups; Amy J Swift; Ann-Christine Syvänen; Tiinamaija Tuomi; Ferdinand M van 't Hooft; Mark Walker; Michael N Weedon; Weijia Xie; Björn Zethelius; Halit Ongen; Anders Mälarstig; Jemma C Hopewell; Danish Saleheen; John Chambers; Sarah Parish; John Danesh; Jaspal Kooner; Claes-Göran Ostenson; Lars Lind; Cyrus C Cooper; Manuel Serrano-Ríos; Ele Ferrannini; Tom J Forsen; Robert Clarke; Maria Grazia Franzosi; Udo Seedorf; Hugh Watkins; Philippe Froguel; Paul Johnson; Panos Deloukas; Francis S Collins; Markku Laakso; Emmanouil T Dermitzakis; Michael Boehnke; Mark I McCarthy; Nicholas J Wareham; Leif Groop; François Pattou; Anna L Gloyn; George V Dedoussis; Valeriya Lyssenko; James B Meigs; Inês Barroso; Richard M Watanabe; Erik Ingelsson; Claudia Langenberg; Anders Hamsten; Jose C Florez
Journal:  Diabetes       Date:  2011-08-26       Impact factor: 9.461

8.  Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes.

Authors:  Gary E Meininger; Russell Scott; Maria Alba; Yue Shentu; Edmund Luo; Himal Amin; Michael J Davies; Keith D Kaufman; Barry J Goldstein
Journal:  Diabetes Care       Date:  2011-10-12       Impact factor: 19.112

9.  Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.

Authors:  Steven E Kahn; John M Lachin; Bernard Zinman; Steven M Haffner; R Paul Aftring; Gitanjali Paul; Barbara G Kravitz; William H Herman; Giancarlo Viberti; Rury R Holman
Journal:  Diabetes       Date:  2011-03-17       Impact factor: 9.461

10.  FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies.

Authors:  Jens K Hertel; Stefan Johansson; Emily Sonestedt; Anna Jonsson; Rolv T Lie; Carl G P Platou; Peter M Nilsson; Gull Rukh; Kristian Midthjell; Kristian Hveem; Olle Melander; Leif Groop; Valeriya Lyssenko; Anders Molven; Marju Orho-Melander; Pål R Njølstad
Journal:  Diabetes       Date:  2011-03-11       Impact factor: 9.461

View more
  7 in total

1.  The villain with a thousand faces.

Authors:  Ashok Balasubramanyam
Journal:  J Diabetes Complications       Date:  2014-02-18       Impact factor: 2.852

2.  Critical role for the Tsc1-mTORC1 pathway in β-cell mass in Pdx1-deficient mice.

Authors:  Juan Sun; Liqun Mao; Hongyan Yang; Decheng Ren
Journal:  J Endocrinol       Date:  2018-06-06       Impact factor: 4.286

3.  Skeletal muscle insulin resistance in zebrafish induces alterations in β-cell number and glucose tolerance in an age- and diet-dependent manner.

Authors:  Lisette A Maddison; Kaitlin E Joest; Ryan M Kammeyer; Wenbiao Chen
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-02-10       Impact factor: 4.310

4.  A combined analysis of 48 type 2 diabetes genetic risk variants shows no discriminative value to predict time to first prescription of a glucose lowering drug in Danish patients with screen detected type 2 diabetes.

Authors:  Malene Hornbak; Kristine Højgaard Allin; Majken Linnemann Jensen; Cathrine Juel Lau; Daniel Witte; Marit Eika Jørgensen; Annelli Sandbæk; Torsten Lauritzen; Åsa Andersson; Oluf Pedersen; Torben Hansen
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

5.  Comparison of the effect of the Dietary Approaches to Stop Hypertension diet with usual dietary advice on expression of peroxisome proliferators-activated receptor gamma gene in women: A randomized controlled clinical trial.

Authors:  Mohammad Hasan Entezari; Rasol Salehi; Mohammad Kazemi; Mohsen Janghorbani; Marzieh Kafeshani
Journal:  ARYA Atheroscler       Date:  2018-01

6.  Ethnic differences in leptin and adiponectin levels between Greenlandic Inuit and Danish children.

Authors:  Thor Munch-Andersen; Kaspar Sorensen; Niels-Jacob Aachmann-Andersen; Lise Aksglaede; Anders Juul; Jørn W Helge
Journal:  Int J Circumpolar Health       Date:  2013-08-07       Impact factor: 1.228

7.  Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes.

Authors:  Claudia H T Tam; Janice S K Ho; Ying Wang; Vincent K L Lam; Heung Man Lee; Guozhi Jiang; Eric S H Lau; Alice P S Kong; Xiaodan Fan; Jean L F Woo; Stephen K W Tsui; Maggie C Y Ng; Wing Yee So; Juliana C N Chan; Ronald C W Ma
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.